Last reviewed · How we verify
NCT04734327: OLDDD
Orthokine Therapy in Lumbar Degenerative Disease
Phase 4 trial testing Orthokine periradicular injection in Degenerative Disc Disease in 100 participants. Status unknown.
31 December 2022
Quick facts
| Lead sponsor | Sutherland Medical Center |
|---|---|
| Phase | Phase 4 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 100 |
| Start date | 1 February 2021 |
| Primary completion | 31 December 2022 |
| Estimated completion | 31 December 2022 |
| Sites | 1 location across Poland |
Drugs / interventions tested
- Orthokine periradicular injection
- Orthokine epidural injection
Conditions studied
- Degenerative Disc Disease — all drugs for Degenerative Disc Disease →
- Lumbar Region — all drugs for Lumbar Region →
Sponsor
Sutherland Medical Center
Who can join
18 and older, any sex, with Degenerative Disc Disease or Lumbar Region. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the trial is the comparison of the effectiveness of two methods of Orthokine administration (periradicular or epidural) in lumbar degenerative disc disease.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Comparison of Analgesic Efficacy between Epidural and Perineural Administration of Autologous Conditioned Serum in the Conservative Treatment of Low Back Pain Due to Lumbar Degenerative Disc Disease: A Randomized, Open-Label, Controlled Clinical Trial.
Godek P, Szczepanowska-Wolowiec B, Golicki D. · · 2023 · cited 3× · PMID 37239221 · DOI 10.3390/brainsci13050749
Verify or expand the search:
- PubMed search for NCT04734327
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Degenerative Disc Disease
Currently open trials in the same condition.
- NCT07254806 — A Study to Evaluate the Effectiveness of IDCT (Intradiscal Cell Therapy) in Subjects With One Level, Symptomatic Mild to · Phase 3 · recruiting
- NCT04679844 — Post Marketing Study of MagnetOs Easypack Putty Standalone Compared to Demineralized Bone Matrix or Fibers Mixed With Au · NA · recruiting
- NCT06704919 — Conduit Cages and Fibergraft BG Putty · recruiting
- NCT06053242 — Safety, Tolerability, and Effectiveness of Intramuscular Injection of CELZ-201-DDT for the Treatment of Chronic Lower Ba · Phase 1, PHASE2 · recruiting
- NCT03810573 — Evaluation of NB1 Bone Graft Following Lumbar Interbody Arthrodesis · NA · recruiting
Other Sutherland Medical Center trials
Trials by the same sponsor.
- NCT04492774 — Degenerative Lumbar Stenosis Conservative Treatment · Phase 4 · unknown
- NCT04492748 — Rotator Cuff Tendinopathy Conservative Treatment With Collagen, PRP or Both · Phase 4 · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04734327 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sutherland Medical Center
- Last refreshed: 2 February 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04734327.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing